MDM2, MDM2 proto-oncogene, 4193

N. diseases: 702; N. variants: 30
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1353702185
rs1353702185
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
CUI: C0007131
Disease:
Non-Small Cell Lung Carcinoma
0.030 GeneticVariation BEFREE In summary, we found that the p53 p. Pro72Arg, MDM2 c.14 + 309T > G and MDM2 c.-461C > G polymorphisms are associated with toxicity risks following platinum-based chemotherapy treatment in advanced NSCLC patients. 25482940 2014
dbSNP: rs2279744
rs2279744
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
CUI: C0007131
Disease:
Non-Small Cell Lung Carcinoma
0.030 GeneticVariation BEFREE This meta-analysis was performed to evaluate the relationships of a common polymorphism (T309G, rs2279744 T>G) in the murine double minute 2 (MDM2) gene with susceptibility and prognosis of nonsmall cell lung cancer (NSCLC). 24673452 2014
dbSNP: rs2279744
rs2279744
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
CUI: C0007131
Disease:
Non-Small Cell Lung Carcinoma
0.030 GeneticVariation BEFREE Specifically, we examined the p53 p. Pro72Arg (rs1042522), MDM2 c.14 + 309T>G (rs2279744) and MDM2 c.- 461C > G (rs937282) polymorphisms using PCR-based restriction fragment length polymorphism (RFLP) in 444 NSCLC patients. 25482940 2014
dbSNP: rs1353702185
rs1353702185
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
CUI: C0007131
Disease:
Non-Small Cell Lung Carcinoma
0.030 GeneticVariation BEFREE This study investigated whether the functional polymorphisms in P53 pathway genes, P53 Arg72Pro (rs1042522), P73 G4C14-to-A4T14 (rs2273953 and rs1801173), and MDM2 T309G (rs2279744), alone or in combination, affect survival in advanced non-small cell lung cancer (NSCLC) patients. 21841506 2011
dbSNP: rs2279744
rs2279744
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
CUI: C0007131
Disease:
Non-Small Cell Lung Carcinoma
0.030 GeneticVariation BEFREE This study investigated whether the functional polymorphisms in P53 pathway genes, P53 Arg72Pro (rs1042522), P73 G4C14-to-A4T14 (rs2273953 and rs1801173), and MDM2 T309G (rs2279744), alone or in combination, affect survival in advanced non-small cell lung cancer (NSCLC) patients. 21841506 2011
dbSNP: rs1353702185
rs1353702185
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
CUI: C0007131
Disease:
Non-Small Cell Lung Carcinoma
0.030 GeneticVariation BEFREE The purpose of the study was to investigate whether polymorphisms of p53 codon 72 (Arg72Pro) and MDM2 SNP309 (309T>G) affect p53 expression and the clinical outcome of patients with advanced nonsmall cell lung cancer (NSCLC). 18618574 2008
dbSNP: rs937282
rs937282
Entrez Id: 4193
Gene Symbol: MDM2
MDM2
CUI: C0007131
Disease:
Non-Small Cell Lung Carcinoma
0.010 GeneticVariation BEFREE Specifically, we examined the p53 p. Pro72Arg (rs1042522), MDM2 c.14 + 309T>G (rs2279744) and MDM2 c.- 461C > G (rs937282) polymorphisms using PCR-based restriction fragment length polymorphism (RFLP) in 444 NSCLC patients. 25482940 2014